ALGS
Price
$6.36
Change
-$0.26 (-3.93%)
Updated
Jul 13 closing price
Capitalization
39.36M
16 days until earnings call
Intraday BUY SELL Signals
CLYM
Price
$13.21
Change
-$0.79 (-5.64%)
Updated
Jul 13 closing price
Capitalization
756.16M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs CLYM

ALGS vs CLYM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALGS vs. CLYM commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a StrongBuy and CLYM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ALGS: $6.36 vs. CLYM: $13.21)
Brand notoriety: ALGS and CLYM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 86% vs. CLYM: 63%
Market capitalization -- ALGS: $39.36M vs. CLYM: $756.16M
ALGS [@Biotechnology] is valued at $39.36M. CLYM’s [@Biotechnology] market capitalization is $756.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileCLYM’s FA Score has 0 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • CLYM’s FA Score: 0 green, 5 red.
According to our system of comparison, CLYM is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 6 TA indicator(s) are bullish while CLYM’s TA Score has 4 bullish TA indicator(s).

  • ALGS’s TA Score: 6 bullish, 4 bearish.
  • CLYM’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than CLYM.

Price Growth

ALGS (@Biotechnology) experienced а +8.72% price change this week, while CLYM (@Biotechnology) price change was -0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

ALGS is expected to report earnings on Jul 30, 2026.

CLYM is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYM($756M) has a higher market cap than ALGS($39.4M). CLYM YTD gains are higher at: 230.250 vs. ALGS (-31.760). CLYM has higher annual earnings (EBITDA): -59.94M vs. ALGS (-92.52M). CLYM has more cash in the bank: 110M vs. ALGS (54.9M). CLYM has less debt than ALGS: CLYM (479K) vs ALGS (4.35M). ALGS has higher revenues than CLYM: ALGS (4.71M) vs CLYM (0).
ALGSCLYMALGS / CLYM
Capitalization39.4M756M5%
EBITDA-92.52M-59.94M154%
Gain YTD-31.760230.250-14%
P/E RatioN/AN/A-
Revenue4.71M0-
Total Cash54.9M110M50%
Total Debt4.35M479K909%
TECHNICAL ANALYSIS
Technical Analysis
ALGSCLYM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
CLYM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMKBX17.01N/A
N/A
Morgan Stanley Inst Emerging Mkts A
GNWRX29.10N/A
N/A
Nationwide R
POICX10.13N/A
N/A
Virtus Tactical Allocation C
JHDRX21.26N/A
N/A
JPMorgan Hedged Equity 2 R6
AFJK12.22-0.47
-3.70%
Aimei Health Technology Co Ltd

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-3.93%
XNCR - ALGS
45%
Loosely correlated
-5.62%
ARVN - ALGS
39%
Loosely correlated
-2.06%
VERA - ALGS
39%
Loosely correlated
-1.19%
PRME - ALGS
38%
Loosely correlated
-7.01%
KURA - ALGS
38%
Loosely correlated
-4.72%
More

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with KYTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
-5.64%
KYTX - CLYM
41%
Loosely correlated
-8.43%
IMVT - CLYM
37%
Loosely correlated
-2.54%
ALGS - CLYM
33%
Poorly correlated
-3.93%
ZNTL - CLYM
33%
Poorly correlated
-5.33%
IMNM - CLYM
32%
Poorly correlated
-2.36%
More